rs720928

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000422939.1(TRPS1):​c.-219+15287T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.689 in 151,986 control chromosomes in the GnomAD database, including 36,925 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.69 ( 36925 hom., cov: 33)

Consequence

TRPS1
ENST00000422939.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.174

Publications

3 publications found
Variant links:
Genes affected
TRPS1 (HGNC:12340): (transcriptional repressor GATA binding 1) This gene encodes a transcription factor that represses GATA-regulated genes and binds to a dynein light chain protein. Binding of the encoded protein to the dynein light chain protein affects binding to GATA consensus sequences and suppresses its transcriptional activity. Defects in this gene are a cause of tricho-rhino-phalangeal syndrome (TRPS) types I-III. [provided by RefSeq, Jul 2008]
TRPS1 Gene-Disease associations (from GenCC):
  • trichorhinophalangeal syndrome type I
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • trichorhinophalangeal syndrome, type III
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • trichorhinophalangeal syndrome type I or III
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRPS1ENST00000422939.1 linkc.-219+15287T>C intron_variant Intron 2 of 4 2 ENSP00000405028.1 C9J6L7

Frequencies

GnomAD3 genomes
AF:
0.689
AC:
104631
AN:
151868
Hom.:
36933
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.524
Gnomad AMI
AF:
0.726
Gnomad AMR
AF:
0.714
Gnomad ASJ
AF:
0.835
Gnomad EAS
AF:
0.638
Gnomad SAS
AF:
0.782
Gnomad FIN
AF:
0.722
Gnomad MID
AF:
0.873
Gnomad NFE
AF:
0.766
Gnomad OTH
AF:
0.726
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.689
AC:
104646
AN:
151986
Hom.:
36925
Cov.:
33
AF XY:
0.687
AC XY:
51013
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.523
AC:
21718
AN:
41488
American (AMR)
AF:
0.714
AC:
10881
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.835
AC:
2897
AN:
3468
East Asian (EAS)
AF:
0.637
AC:
3278
AN:
5144
South Asian (SAS)
AF:
0.784
AC:
3780
AN:
4824
European-Finnish (FIN)
AF:
0.722
AC:
7616
AN:
10550
Middle Eastern (MID)
AF:
0.871
AC:
256
AN:
294
European-Non Finnish (NFE)
AF:
0.766
AC:
52034
AN:
67952
Other (OTH)
AF:
0.724
AC:
1524
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1614
3228
4842
6456
8070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
822
1644
2466
3288
4110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.718
Hom.:
4703
Bravo
AF:
0.683
Asia WGS
AF:
0.683
AC:
2372
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.1
DANN
Benign
0.53
PhyloP100
-0.17

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs720928; hg19: chr8-116697876; API